Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1384960

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1384960

Asia Pacific Non-invasive Prenatal Testing (NIPT) Market Size, Share & Industry Trends Analysis Report By Product, By Application, By End User (Diagnostic Laboratories, Hospitals & Clinics), By Technology, By Country and Growth Forecast, 2023 - 2030

PUBLISHED:
PAGES: 143 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The Asia Pacific Non-invasive Prenatal Testing (NIPT) Market would witness market growth of 19.1% CAGR during the forecast period (2023-2030).

Prenatal care has undergone a revolutionary change due to non-invasive prenatal testing (NIPT), which has changed how expectant parents and medical professionals screen for chromosomal and genetic diseases in unborn babies. This non-invasive, highly accurate, and early screening method has gained remarkable traction in recent years, significantly impacting the landscape of prenatal testing and maternal healthcare. NIPT has witnessed widespread adoption, exhibited remarkable application in identifying foetal abnormalities, demonstrated notable trends, and seen continuous innovation, thus promising a brighter future for prenatal care.

NIPT offers a higher level of accuracy compared to traditional prenatal screening methods. It can detect a wide range of chromosomal abnormalities with a lower false-positive rate, giving parents more confidence in the results. Contrary to invasive treatments like amniocentesis or chorionic villus sampling (CVS), NIPT is non-invasive and provides little risk to the mother and the foetus. This considerably lowers the possibility of issues and miscarriages brought on by invasive testing.

The Chinese government's commitment to achieving universal healthcare coverage and reducing healthcare disparities has sparked significant investments in healthcare access and infrastructure development. China has implemented a comprehensive health insurance system, the most well-known being the New Rural Cooperative Medical Scheme (NRCMS) and the Urban Employee Basic Medical Insurance (UEBMI). Owing to the rise in healthcare spending in the Asia Pacific region, the demand for these will increase in the region.

The China market dominated the Asia Pacific Non-invasive Prenatal Testing (NIPT) Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,236.2 Million by 2030. The Japan market is registering a CAGR of 18.3% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 19.8% during (2023 - 2030).

Based on Product, the market is segmented into Consumables & Reagents, and Instruments. Based on Application, the market is segmented into Trisomy, Microdeletion Syndrome, and Others. Based on End User, the market is segmented into Diagnostic Laboratories, Hospitals & Clinics. Based on Technology, the market is segmented into Next Generation Sequencing (NGS), Microarray, Polymerase Chain Reaction (PCR), and Rolling Circular Amplification. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Illumina, Inc., Natera Inc., F. Hoffmann-La Roche Ltd., PerkinElmer, Inc., Laboratory Corporation of America Holdings, Eurofins Scientific SE, Thermo Fisher Scientific, Inc., GE HealthCare Technologies, Inc., Agilent Technologies, Inc., and Pacific Biosciences of California, Inc.

Scope of the Study

Market Segments covered in the Report:

By Product

  • Consumables & Reagents
  • Instruments

By Application

  • Trisomy
  • Microdeletion Syndrome
  • Others

By End User

  • Diagnostic Laboratories
  • Hospitals & Clinics

By Technology

  • Next Generation Sequencing (NGS)
  • Microarray
  • Polymerase Chain Reaction (PCR)
  • Rolling Circular Amplification

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Companies Profiled

  • Illumina, Inc.
  • Natera Inc.
  • F. Hoffmann-La Roche Ltd.
  • PerkinElmer, Inc.
  • Laboratory Corporation of America Holdings
  • Eurofins Scientific SE
  • Thermo Fisher Scientific, Inc.
  • GE HealthCare Technologies, Inc.
  • Agilent Technologies, Inc.
  • Pacific Biosciences of California, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Asia Pacific Non-invasive Prenatal Testing (NIPT) Market, by Product
    • 1.4.2 Asia Pacific Non-invasive Prenatal Testing (NIPT) Market, by Application
    • 1.4.3 Asia Pacific Non-invasive Prenatal Testing (NIPT) Market, by End User
    • 1.4.4 Asia Pacific Non-invasive Prenatal Testing (NIPT) Market, by Technology
    • 1.4.5 Asia Pacific Non-invasive Prenatal Testing (NIPT) Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
  • 3.3 Porter Five Forces Analysis

Chapter 4. Asia Pacific Non-invasive Prenatal Testing (NIPT) Market by Product

  • 4.1 Asia Pacific Consumables & Reagents Market by Country
  • 4.2 Asia Pacific Instruments Market by Country

Chapter 5. Asia Pacific Non-invasive Prenatal Testing (NIPT) Market by Application

  • 5.1 Asia Pacific Trisomy Market by Country
  • 5.2 Asia Pacific Microdeletion Syndrome Market by Country
  • 5.3 Asia Pacific Others Market by Country

Chapter 6. Asia Pacific Non-invasive Prenatal Testing (NIPT) Market by End User

  • 6.1 Asia Pacific Diagnostic Laboratories Market by Country
  • 6.2 Asia Pacific Hospitals & Clinics Market by Country

Chapter 7. Asia Pacific Non-invasive Prenatal Testing (NIPT) Market by Technology

  • 7.1 Asia Pacific Next Generation Sequencing (NGS) Market by Country
  • 7.2 Asia Pacific Microarray Market by Country
  • 7.3 Asia Pacific Polymerase Chain Reaction (PCR) Market by Country
  • 7.4 Asia Pacific Rolling Circular Amplification Market by Country

Chapter 8. Asia Pacific Non-invasive Prenatal Testing (NIPT) Market by Country

  • 8.1 China Non-invasive Prenatal Testing (NIPT) Market
    • 8.1.1 China Non-invasive Prenatal Testing (NIPT) Market by Product
    • 8.1.2 China Non-invasive Prenatal Testing (NIPT) Market by Application
    • 8.1.3 China Non-invasive Prenatal Testing (NIPT) Market by End User
    • 8.1.4 China Non-invasive Prenatal Testing (NIPT) Market by Technology
  • 8.2 Japan Non-invasive Prenatal Testing (NIPT) Market
    • 8.2.1 Japan Non-invasive Prenatal Testing (NIPT) Market by Product
    • 8.2.2 Japan Non-invasive Prenatal Testing (NIPT) Market by Application
    • 8.2.3 Japan Non-invasive Prenatal Testing (NIPT) Market by End User
    • 8.2.4 Japan Non-invasive Prenatal Testing (NIPT) Market by Technology
  • 8.3 India Non-invasive Prenatal Testing (NIPT) Market
    • 8.3.1 India Non-invasive Prenatal Testing (NIPT) Market by Product
    • 8.3.2 India Non-invasive Prenatal Testing (NIPT) Market by Application
    • 8.3.3 India Non-invasive Prenatal Testing (NIPT) Market by End User
    • 8.3.4 India Non-invasive Prenatal Testing (NIPT) Market by Technology
  • 8.4 South Korea Non-invasive Prenatal Testing (NIPT) Market
    • 8.4.1 South Korea Non-invasive Prenatal Testing (NIPT) Market by Product
    • 8.4.2 South Korea Non-invasive Prenatal Testing (NIPT) Market by Application
    • 8.4.3 South Korea Non-invasive Prenatal Testing (NIPT) Market by End User
    • 8.4.4 South Korea Non-invasive Prenatal Testing (NIPT) Market by Technology
  • 8.5 Singapore Non-invasive Prenatal Testing (NIPT) Market
    • 8.5.1 Singapore Non-invasive Prenatal Testing (NIPT) Market by Product
    • 8.5.2 Singapore Non-invasive Prenatal Testing (NIPT) Market by Application
    • 8.5.3 Singapore Non-invasive Prenatal Testing (NIPT) Market by End User
    • 8.5.4 Singapore Non-invasive Prenatal Testing (NIPT) Market by Technology
  • 8.6 Malaysia Non-invasive Prenatal Testing (NIPT) Market
    • 8.6.1 Malaysia Non-invasive Prenatal Testing (NIPT) Market by Product
    • 8.6.2 Malaysia Non-invasive Prenatal Testing (NIPT) Market by Application
    • 8.6.3 Malaysia Non-invasive Prenatal Testing (NIPT) Market by End User
    • 8.6.4 Malaysia Non-invasive Prenatal Testing (NIPT) Market by Technology
  • 8.7 Rest of Asia Pacific Non-invasive Prenatal Testing (NIPT) Market
    • 8.7.1 Rest of Asia Pacific Non-invasive Prenatal Testing (NIPT) Market by Product
    • 8.7.2 Rest of Asia Pacific Non-invasive Prenatal Testing (NIPT) Market by Application
    • 8.7.3 Rest of Asia Pacific Non-invasive Prenatal Testing (NIPT) Market by End User
    • 8.7.4 Rest of Asia Pacific Non-invasive Prenatal Testing (NIPT) Market by Technology

Chapter 9. Company Profiles

  • 9.1 Illumina, Inc.
    • 9.1.1 Company Overview
    • 9.1.2 Financial Analysis
    • 9.1.3 Regional Analysis
    • 9.1.4 Research & Development Expense
    • 9.1.5 Recent strategies and developments:
      • 9.1.5.1 Partnerships, Collaborations, and Agreements:
      • 9.1.5.2 Acquisition and Mergers:
    • 9.1.6 SWOT Analysis
  • 9.2 Natera Inc.
    • 9.2.1 Company Overview
    • 9.2.2 Financial Analysis
    • 9.2.3 Regional Analysis
    • 9.2.4 Research & Development Expenses
    • 9.2.5 SWOT Analysis
  • 9.3 F. Hoffmann-La Roche Ltd.
    • 9.3.1 Company Overview
    • 9.3.2 Financial Analysis
    • 9.3.3 Segmental and Regional Analysis
    • 9.3.4 Research & Development Expense
    • 9.3.5 SWOT Analysis
  • 9.4 PerkinElmer, Inc.
    • 9.4.1 Company Overview
    • 9.4.2 Financial Analysis
    • 9.4.3 Segmental and Regional Analysis
    • 9.4.4 Research & Development Expense
    • 9.4.5 Recent strategies and developments:
      • 9.4.5.1 Acquisition and Mergers:
    • 9.4.6 SWOT Analysis
  • 9.5 Laboratory Corporation of America Holdings
    • 9.5.1 Company Overview
    • 9.5.2 Financial Analysis
    • 9.5.3 Segmental Analysis
    • 9.5.4 SWOT Analysis
  • 9.6 Eurofins Scientific SE
    • 9.6.1 Company Overview
    • 9.6.2 Financial Analysis
    • 9.6.3 Regional Analysis
    • 9.6.4 Recent strategies and developments:
      • 9.6.4.1 Product Launches and Product Expansions:
    • 9.6.5 SWOT Analysis
  • 9.7 Thermo Fisher Scientific, Inc.
    • 9.7.1 Company Overview
    • 9.7.2 Financial Analysis
    • 9.7.3 Segmental and Regional Analysis
    • 9.7.4 Research & Development Expenses
    • 9.7.5 WOT Analysis
  • 9.8 GE HealthCare Technologies, Inc.
    • 9.8.1 Company Overview
    • 9.8.2 Financial Analysis
    • 9.8.3 Segmental and Regional Analysis
    • 9.8.4 Research & Development Expenses
    • 9.8.5 Recent strategies and developments:
      • 9.8.5.1 Product Launches and Product Expansions:
      • 9.8.5.2 Acquisition and Mergers:
    • 9.8.6 SWOT Analysis
  • 9.9 Agilent Technologies, Inc.
    • 9.9.1 Company Overview
    • 9.9.2 Financial Analysis
    • 9.9.3 Segmental and Regional Analysis
    • 9.9.4 Research & Development Expense
    • 9.9.5 SWOT Analysis
  • 9.10. Pacific Biosciences of California, Inc.
    • 9.10.1 Company Overview
    • 9.10.2 Financial Analysis
    • 9.10.3 Regional Analysis
    • 9.10.4 Research & Development Expenses
    • 9.10.5 Recent strategies and developments:
      • 9.10.5.1 Acquisition and Mergers:
    • 9.10.6 SWOT Analysis

LIST OF TABLES

  • TABLE 1 Asia Pacific Non-invasive Prenatal Testing (NIPT) Market, 2019 - 2022, USD Million
  • TABLE 2 Asia Pacific Non-invasive Prenatal Testing (NIPT) Market, 2023 - 2030, USD Million
  • TABLE 3 Asia Pacific Non-invasive Prenatal Testing (NIPT) Market by Product, 2019 - 2022, USD Million
  • TABLE 4 Asia Pacific Non-invasive Prenatal Testing (NIPT) Market by Product, 2023 - 2030, USD Million
  • TABLE 5 Asia Pacific Consumables & Reagents Market by Country, 2019 - 2022, USD Million
  • TABLE 6 Asia Pacific Consumables & Reagents Market by Country, 2023 - 2030, USD Million
  • TABLE 7 Asia Pacific Instruments Market by Country, 2019 - 2022, USD Million
  • TABLE 8 Asia Pacific Instruments Market by Country, 2023 - 2030, USD Million
  • TABLE 9 Asia Pacific Non-invasive Prenatal Testing (NIPT) Market by Application, 2019 - 2022, USD Million
  • TABLE 10 Asia Pacific Non-invasive Prenatal Testing (NIPT) Market by Application, 2023 - 2030, USD Million
  • TABLE 11 Asia Pacific Trisomy Market by Country, 2019 - 2022, USD Million
  • TABLE 12 Asia Pacific Trisomy Market by Country, 2023 - 2030, USD Million
  • TABLE 13 Asia Pacific Microdeletion Syndrome Market by Country, 2019 - 2022, USD Million
  • TABLE 14 Asia Pacific Microdeletion Syndrome Market by Country, 2023 - 2030, USD Million
  • TABLE 15 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
  • TABLE 16 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
  • TABLE 17 Asia Pacific Non-invasive Prenatal Testing (NIPT) Market by End User, 2019 - 2022, USD Million
  • TABLE 18 Asia Pacific Non-invasive Prenatal Testing (NIPT) Market by End User, 2023 - 2030, USD Million
  • TABLE 19 Asia Pacific Diagnostic Laboratories Market by Country, 2019 - 2022, USD Million
  • TABLE 20 Asia Pacific Diagnostic Laboratories Market by Country, 2023 - 2030, USD Million
  • TABLE 21 Asia Pacific Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
  • TABLE 22 Asia Pacific Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
  • TABLE 23 Asia Pacific Non-invasive Prenatal Testing (NIPT) Market by Technology, 2019 - 2022, USD Million
  • TABLE 24 Asia Pacific Non-invasive Prenatal Testing (NIPT) Market by Technology, 2023 - 2030, USD Million
  • TABLE 25 Asia Pacific Next Generation Sequencing (NGS) Market by Country, 2019 - 2022, USD Million
  • TABLE 26 Asia Pacific Next Generation Sequencing (NGS) Market by Country, 2023 - 2030, USD Million
  • TABLE 27 Asia Pacific Microarray Market by Country, 2019 - 2022, USD Million
  • TABLE 28 Asia Pacific Microarray Market by Country, 2023 - 2030, USD Million
  • TABLE 29 Asia Pacific Polymerase Chain Reaction (PCR) Market by Country, 2019 - 2022, USD Million
  • TABLE 30 Asia Pacific Polymerase Chain Reaction (PCR) Market by Country, 2023 - 2030, USD Million
  • TABLE 31 Asia Pacific Rolling Circular Amplification Market by Country, 2019 - 2022, USD Million
  • TABLE 32 Asia Pacific Rolling Circular Amplification Market by Country, 2023 - 2030, USD Million
  • TABLE 33 Asia Pacific Non-invasive Prenatal Testing (NIPT) Market by Country, 2019 - 2022, USD Million
  • TABLE 34 Asia Pacific Non-invasive Prenatal Testing (NIPT) Market by Country, 2023 - 2030, USD Million
  • TABLE 35 China Non-invasive Prenatal Testing (NIPT) Market, 2019 - 2022, USD Million
  • TABLE 36 China Non-invasive Prenatal Testing (NIPT) Market, 2023 - 2030, USD Million
  • TABLE 37 China Non-invasive Prenatal Testing (NIPT) Market by Product, 2019 - 2022, USD Million
  • TABLE 38 China Non-invasive Prenatal Testing (NIPT) Market by Product, 2023 - 2030, USD Million
  • TABLE 39 China Non-invasive Prenatal Testing (NIPT) Market by Application, 2019 - 2022, USD Million
  • TABLE 40 China Non-invasive Prenatal Testing (NIPT) Market by Application, 2023 - 2030, USD Million
  • TABLE 41 China Non-invasive Prenatal Testing (NIPT) Market by End User, 2019 - 2022, USD Million
  • TABLE 42 China Non-invasive Prenatal Testing (NIPT) Market by End User, 2023 - 2030, USD Million
  • TABLE 43 China Non-invasive Prenatal Testing (NIPT) Market by Technology, 2019 - 2022, USD Million
  • TABLE 44 China Non-invasive Prenatal Testing (NIPT) Market by Technology, 2023 - 2030, USD Million
  • TABLE 45 Japan Non-invasive Prenatal Testing (NIPT) Market, 2019 - 2022, USD Million
  • TABLE 46 Japan Non-invasive Prenatal Testing (NIPT) Market, 2023 - 2030, USD Million
  • TABLE 47 Japan Non-invasive Prenatal Testing (NIPT) Market by Product, 2019 - 2022, USD Million
  • TABLE 48 Japan Non-invasive Prenatal Testing (NIPT) Market by Product, 2023 - 2030, USD Million
  • TABLE 49 Japan Non-invasive Prenatal Testing (NIPT) Market by Application, 2019 - 2022, USD Million
  • TABLE 50 Japan Non-invasive Prenatal Testing (NIPT) Market by Application, 2023 - 2030, USD Million
  • TABLE 51 Japan Non-invasive Prenatal Testing (NIPT) Market by End User, 2019 - 2022, USD Million
  • TABLE 52 Japan Non-invasive Prenatal Testing (NIPT) Market by End User, 2023 - 2030, USD Million
  • TABLE 53 Japan Non-invasive Prenatal Testing (NIPT) Market by Technology, 2019 - 2022, USD Million
  • TABLE 54 Japan Non-invasive Prenatal Testing (NIPT) Market by Technology, 2023 - 2030, USD Million
  • TABLE 55 India Non-invasive Prenatal Testing (NIPT) Market, 2019 - 2022, USD Million
  • TABLE 56 India Non-invasive Prenatal Testing (NIPT) Market, 2023 - 2030, USD Million
  • TABLE 57 India Non-invasive Prenatal Testing (NIPT) Market by Product, 2019 - 2022, USD Million
  • TABLE 58 India Non-invasive Prenatal Testing (NIPT) Market by Product, 2023 - 2030, USD Million
  • TABLE 59 India Non-invasive Prenatal Testing (NIPT) Market by Application, 2019 - 2022, USD Million
  • TABLE 60 India Non-invasive Prenatal Testing (NIPT) Market by Application, 2023 - 2030, USD Million
  • TABLE 61 India Non-invasive Prenatal Testing (NIPT) Market by End User, 2019 - 2022, USD Million
  • TABLE 62 India Non-invasive Prenatal Testing (NIPT) Market by End User, 2023 - 2030, USD Million
  • TABLE 63 India Non-invasive Prenatal Testing (NIPT) Market by Technology, 2019 - 2022, USD Million
  • TABLE 64 India Non-invasive Prenatal Testing (NIPT) Market by Technology, 2023 - 2030, USD Million
  • TABLE 65 South Korea Non-invasive Prenatal Testing (NIPT) Market, 2019 - 2022, USD Million
  • TABLE 66 South Korea Non-invasive Prenatal Testing (NIPT) Market, 2023 - 2030, USD Million
  • TABLE 67 South Korea Non-invasive Prenatal Testing (NIPT) Market by Product, 2019 - 2022, USD Million
  • TABLE 68 South Korea Non-invasive Prenatal Testing (NIPT) Market by Product, 2023 - 2030, USD Million
  • TABLE 69 South Korea Non-invasive Prenatal Testing (NIPT) Market by Application, 2019 - 2022, USD Million
  • TABLE 70 South Korea Non-invasive Prenatal Testing (NIPT) Market by Application, 2023 - 2030, USD Million
  • TABLE 71 South Korea Non-invasive Prenatal Testing (NIPT) Market by End User, 2019 - 2022, USD Million
  • TABLE 72 South Korea Non-invasive Prenatal Testing (NIPT) Market by End User, 2023 - 2030, USD Million
  • TABLE 73 South Korea Non-invasive Prenatal Testing (NIPT) Market by Technology, 2019 - 2022, USD Million
  • TABLE 74 South Korea Non-invasive Prenatal Testing (NIPT) Market by Technology, 2023 - 2030, USD Million
  • TABLE 75 Singapore Non-invasive Prenatal Testing (NIPT) Market, 2019 - 2022, USD Million
  • TABLE 76 Singapore Non-invasive Prenatal Testing (NIPT) Market, 2023 - 2030, USD Million
  • TABLE 77 Singapore Non-invasive Prenatal Testing (NIPT) Market by Product, 2019 - 2022, USD Million
  • TABLE 78 Singapore Non-invasive Prenatal Testing (NIPT) Market by Product, 2023 - 2030, USD Million
  • TABLE 79 Singapore Non-invasive Prenatal Testing (NIPT) Market by Application, 2019 - 2022, USD Million
  • TABLE 80 Singapore Non-invasive Prenatal Testing (NIPT) Market by Application, 2023 - 2030, USD Million
  • TABLE 81 Singapore Non-invasive Prenatal Testing (NIPT) Market by End User, 2019 - 2022, USD Million
  • TABLE 82 Singapore Non-invasive Prenatal Testing (NIPT) Market by End User, 2023 - 2030, USD Million
  • TABLE 83 Singapore Non-invasive Prenatal Testing (NIPT) Market by Technology, 2019 - 2022, USD Million
  • TABLE 84 Singapore Non-invasive Prenatal Testing (NIPT) Market by Technology, 2023 - 2030, USD Million
  • TABLE 85 Malaysia Non-invasive Prenatal Testing (NIPT) Market, 2019 - 2022, USD Million
  • TABLE 86 Malaysia Non-invasive Prenatal Testing (NIPT) Market, 2023 - 2030, USD Million
  • TABLE 87 Malaysia Non-invasive Prenatal Testing (NIPT) Market by Product, 2019 - 2022, USD Million
  • TABLE 88 Malaysia Non-invasive Prenatal Testing (NIPT) Market by Product, 2023 - 2030, USD Million
  • TABLE 89 Malaysia Non-invasive Prenatal Testing (NIPT) Market by Application, 2019 - 2022, USD Million
  • TABLE 90 Malaysia Non-invasive Prenatal Testing (NIPT) Market by Application, 2023 - 2030, USD Million
  • TABLE 91 Malaysia Non-invasive Prenatal Testing (NIPT) Market by End User, 2019 - 2022, USD Million
  • TABLE 92 Malaysia Non-invasive Prenatal Testing (NIPT) Market by End User, 2023 - 2030, USD Million
  • TABLE 93 Malaysia Non-invasive Prenatal Testing (NIPT) Market by Technology, 2019 - 2022, USD Million
  • TABLE 94 Malaysia Non-invasive Prenatal Testing (NIPT) Market by Technology, 2023 - 2030, USD Million
  • TABLE 95 Rest of Asia Pacific Non-invasive Prenatal Testing (NIPT) Market, 2019 - 2022, USD Million
  • TABLE 96 Rest of Asia Pacific Non-invasive Prenatal Testing (NIPT) Market, 2023 - 2030, USD Million
  • TABLE 97 Rest of Asia Pacific Non-invasive Prenatal Testing (NIPT) Market by Product, 2019 - 2022, USD Million
  • TABLE 98 Rest of Asia Pacific Non-invasive Prenatal Testing (NIPT) Market by Product, 2023 - 2030, USD Million
  • TABLE 99 Rest of Asia Pacific Non-invasive Prenatal Testing (NIPT) Market by Application, 2019 - 2022, USD Million
  • TABLE 100 Rest of Asia Pacific Non-invasive Prenatal Testing (NIPT) Market by Application, 2023 - 2030, USD Million
  • TABLE 101 Rest of Asia Pacific Non-invasive Prenatal Testing (NIPT) Market by End User, 2019 - 2022, USD Million
  • TABLE 102 Rest of Asia Pacific Non-invasive Prenatal Testing (NIPT) Market by End User, 2023 - 2030, USD Million
  • TABLE 103 Rest of Asia Pacific Non-invasive Prenatal Testing (NIPT) Market by Technology, 2019 - 2022, USD Million
  • TABLE 104 Rest of Asia Pacific Non-invasive Prenatal Testing (NIPT) Market by Technology, 2023 - 2030, USD Million
  • TABLE 105 key information - Illumina, Inc.
  • TABLE 106 Key Information - Natera Inc.
  • TABLE 107 Key Information - F. Hoffmann-La Roche Ltd.
  • TABLE 108 key Information - PerkinElmer, Inc.
  • TABLE 109 Key Information - Laboratory Corporation of America holdings
  • TABLE 110 Key Information - Eurofins Scientific SE
  • TABLE 111 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 112 Key Information - GE HealthCare Technologies, Inc.
  • TABLE 113 key Information - Agilent Technologies, Inc.
  • TABLE 114 Key Information - Pacific Biosciences of California, Inc.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!